BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ge Y, Long Y, Xiao S, Liang L, He Z, Yue C, Wei X, Zhou Y. CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells. Int J Oncol 2019;54:585-99. [PMID: 30535454 DOI: 10.3892/ijo.2018.4651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 He Z, Yue C, Chen X, Li X, Zhang L, Tan S, Yi X, Luo G, Zhou Y. Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer. J Cancer 2023;14:72-87. [PMID: 36605482 DOI: 10.7150/jca.59730] [Reference Citation Analysis]
2 Shao X, Hua S, Feng T, Ocansey DKW, Yin L. Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion. IJMS 2022;23:11789. [DOI: 10.3390/ijms231911789] [Reference Citation Analysis]
3 Liu W, Yang HS, Zheng SY, Luo HH, Feng YF, Lei YY. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration. BMC Bioinformatics 2022;23:406. [PMID: 36180848 DOI: 10.1186/s12859-022-04956-9] [Reference Citation Analysis]
4 Szlasa W, Czarny J, Sauer N, Rakoczy K, Szymańska N, Stecko J, Kołodziej M, Kaźmierczak M, Barg E. Targeting CD38 in Neoplasms and Non-Cancer Diseases. Cancers 2022;14:4169. [DOI: 10.3390/cancers14174169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Duan Y, Chen R, Huang Y, Meng X, Chen J, Liao C, Tang Y, Zhou C, Gao X, Sun J. Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy. Cell Mol Life Sci 2021;79:14. [PMID: 34966954 DOI: 10.1007/s00018-021-04089-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ding Z, He Y, Fu Y, Zhu N, Zhao M, Song Y, Huang X, Chen S, Yang Y, Zhang C, Hu Q, Ni Y, Ding L. CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint. Front Oncol 2021;11:687430. [PMID: 34211854 DOI: 10.3389/fonc.2021.687430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Angelicola S, Ruzzi F, Landuzzi L, Scalambra L, Gelsomino F, Ardizzoni A, Nanni P, Lollini PL, Palladini A. IFN-γ and CD38 in Hyperprogressive Cancer Development. Cancers (Basel) 2021;13:309. [PMID: 33467713 DOI: 10.3390/cancers13020309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kincaid JW, Berger NA. NAD metabolism in aging and cancer. Exp Biol Med (Maywood) 2020;245:1594-614. [PMID: 32500741 DOI: 10.1177/1535370220929287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]